Poor evidence occludes locally advanced RCC surgery recommendations
Researchers have failed to find sufficient evidence to conclude whether concomitant lymph node dissection or ipsilateral adrenalectomy with radical nephrectomy improves oncologic outcomes for patients with locally advanced renal cell carcinoma. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 26, 2013 Category: Cancer & Oncology Source Type: news
Polyp growth identifies colorectal cancer
Monitoring colorectal polyp growth with computed tomography could help target treatment in patients undergoing routine colorectal cancer surveillance, research suggests. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 19, 2013 Category: Cancer & Oncology Source Type: news
Early motherhood reduces kidney cancer risk
Data from Taiwan suggest that a younger age at first birth may be protective against kidney cancer in women. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 17, 2013 Category: Cancer & Oncology Source Type: news
Transperineal prostate biopsy shows core–complication connection
Research shows that clinical complications after transperineal prostate biopsy are common, but rarely result in hospital admission. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 10, 2013 Category: Cancer & Oncology Source Type: news
Silenced miR points to poor SCLC prognosis
Chinese scientists have identified a molecular marker that significantly predicts the survival of patients with small-cell lung cancer. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 7, 2013 Category: Cancer & Oncology Source Type: news
Age, node status predict lung cancer surgery survival
Age and node status are the strongest prognostic factors for patients considering T4 lung cancer resection, results from the Japanese Lung Cancer Registry show. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 7, 2013 Category: Cancer & Oncology Source Type: news
HER2 screening recommended for lung adenocarcinoma patients
Researchers highlight the importance of testing for HER2 mutations in patients with non-small-cell lung cancer, adding to evidence that supports the use of HER2-targeted drugs in this population. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 6, 2013 Category: Cancer & Oncology Source Type: news
Primary care physicians boost prostate cancer BMD monitoring
A US study has found that rates of bone mineral density testing in men with prostate cancer receiving androgen deprivation therapy are highest among those whose primary care physician is involved in their care. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 3, 2013 Category: Cancer & Oncology Source Type: news
Pyuria predicts poor outcome in NMIBC
Japanese research shows that pyuria at diagnosis is independently associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 3, 2013 Category: Cancer & Oncology Source Type: news
KRAS mutation fails to predict NSCLC chemotherapy success
Research casts doubt on the ability of the KRAS mutation to aid the selection of patients with non-small-cell lung cancer to receive adjuvant chemotherapy. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 3, 2013 Category: Cancer & Oncology Source Type: news
Primary NSCLC shares mutations with metastases
Scientists have found a high level of concordance in the genetic mutations of pairs of primary non-small-cell lung cancer and metachronous or synchronous metastases. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 3, 2013 Category: Cancer & Oncology Source Type: news
nab-paclitaxel promising for Japanese NSCLC patients
Phase III trial results support the use of albumin-bound paclitaxel plus carboplatin as a first-line treatment for Japanese patients with advanced non-small-cell lung cancer. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 1, 2013 Category: Cancer & Oncology Source Type: news
Selective ALK inhibitor shows NSCLC promise
Preliminary trial results suggest that a novel, highly selective ALK inhibitor may be effective for the treatment of advanced non-small-cell lung cancer in Japanese patients with the ALK rearrangement. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 30, 2013 Category: Cancer & Oncology Source Type: news
Late radiotherapy ‘not inferior’ for patients
Researchers have questioned the timing of thoracic radiotherapy for patients undergoing four cycles of chemotherapy for limited-disease small-cell lung cancer. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 30, 2013 Category: Cancer & Oncology Source Type: news
IMRT shows rapid uptake but fails to outperform CRT
Intensity-modulated radiotherapy is equivalent to conventional conformal radiotherapy in terms of morbidity and cancer control outcomes in the treatment of prostate cancer after radical prostatectomy, shows a study published in JAMA Internal Medicine. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 28, 2013 Category: Cancer & Oncology Source Type: news
